Report
Pierre Tegner

Danone : Warning on Q2 and cost overruns. EPS estimated at -15% in H1. The medium-term depends on the “adjustment plan” to be announced end-2020.

>The favourable momentum since Q1 will have proved short-lived - Reduce rating maintained with a target price lowered to € 57 (vs € 60 previously). At the AGM on Friday, Danone’s CFO and CEO provided guidance on Q2, which was described as “exceptionally weak”, and also on the cost of growth in H1. The information provided in the press release that followed (waters down -30% in Q2 and additional operating costs of € 100m in H1) enable us to estimate that underlying dil...
Underlying
Danone SA

Danone is engaged in activities in the global food and beverages industry. Co. operates in four markets: Fresh Dairy Products (Co. produces and sells yogurts, fermented dairy products and other fresh dairy products); Waters (Co. produces and sells natural waters as well as flavored and vitamin-enriched waters products); Early Life Nutrition (Co. produces baby formula, milk-and fruit-based desserts, cereals, small pots of baby food and ready-made baby food); and Medical Nutrition (Co. develops adult and pediatric clinical nutrition products to be taken orally, or through a catheter in the event of malnutrition related to illness or other causes).

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Pierre Tegner

Other Reports on these Companies
Other Reports from Oddo BHF
Olfa Taamallah ... (+2)
  • Olfa Taamallah
  • Yan Derocles
Cor Kluis ... (+2)
  • Cor Kluis
  • Julian Dobrovolschi

ResearchPool Subscriptions

Get the most out of your insights

Get in touch